New drug LG-0317 tested in people for the first time
Knowledge-focused
Recruiting now
This early-stage study is the first time LG-0317 is given to humans. It involves 100 healthy Chinese adults aged 18-45 to check the drug's safety and how the body processes it. Participants receive either the drug or a placebo in single or multiple doses. The goal is to gather sa…
Phase: PHASE1 • Sponsor: LinGang Laboratory • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC